[Results of treatment of bacterial inflammation of the skin with enoxacin].

In a microbiologically controlled, open study the 4-quinolone derivative enoxacin was tested in 51 patients suffering from infectious dermatoses. Clinical cure or improvement was observed in 91% of the patients, microbiological cure occurred in 65%. According to the results of our trial enoxacin is recommended as a therapeutic alternative, especially for the treatment of dermatitis caused by gram-negative bacilli.